Anthem Biosciences Ipo
Objects of the Issue
The Company will not receive any proceeds from the Offer (the “Offer Proceeds”) and all the Offer Proceeds will be received by the Selling Shareholders after deduction of Offer related expenses and relevant taxes thereon, to be borne by the respective Selling Shareholders.
Anthem Biosciences IPO Review
IPO Watch – May Apply
Canara Bank –
DRChoksey FinServ –
Emkay Global –
Hem Securities –
IDBI Capital –
Marwadi Shares –
Nirmal Bang –
SBICAP Securities –
Sharekhan –
SMC Global –
Sushil Finance –
Swastika Investmart –
Ventura Securities –
Geojit –
Reliance Securities –
Capital Market –
BP Wealth –
ICICIdirect –
Choice Broking –
IPO Lead Managers aka Merchant Bankers
Jm Financial Limited
Citigroup Global Markets India Private Limited
J.P. Morgan India Private Limited
Nomura Financial Advisory And Securities (India) Pvt Ltd
Application | Lot Size | Shares | Amount |
Retail Minimum | 1 | 26 | ₹14,820 |
Retail Maximum | 13 | 338 | ₹1,92,660 |
S-HNI Minimum | 14 | 364 | ₹2,07,480 |
B-HNI Minimum | 68 | 1,768 | ₹10,07,760 |
IPO Open Date: | July 14, 2025 |
IPO Close Date: | July 16, 2025 |
Basis of Allotment: | July 17, 2025 |
Refunds: | July 18, 2025 |
Credit to Demat Account: | July 18, 2025 |
IPO Listing Date: | July 21, 2025 |
Period Ended | Revenue | Expense | Profit After Tax | Assets |
2022 | ₹1,280.24 | ₹734.10 | ₹405.54 | ₹1,618.87 |
2023 | ₹1,133.99 | ₹698.50 | ₹385.19 | ₹2,014.46 |
2024 | ₹1,483.07 | ₹1,005.75 | ₹367.31 | ₹2,398.11 |
2025 | ₹1,930.29 | ₹1,273.42 | ₹451.26 | ₹2,807.58 |
KPI | Values |
ROE: | 20.82% |
ROCE: | 27.64% |
EBITDA Margin: | 36.81% |
PAT Margin: | 23.38% |
Debt to equity ratio: | 0.05 |
Earning Per Share (EPS): | ₹8.07 (Basic) |
Price/Earning P/E Ratio: | N/A |
Return on Net Worth (RoNW): | 20.82% |
Net Asset Value (NAV): | ₹43.10 |
Company | EPS | PE Ratio | RoNW % | NAV | Income |
Syngene International Limited | 12.35 | 51.54 | 11.05% | 117.42 | 3,642.40 Cr. |
Sai Life Sciences Limited | 8.83 | 92.18 | 10.96% | 102.12 | 1,694.57 Cr. |
Suven Life Sciences Limited | 10.52 | 97.29 | 13.61% | 72.31 | 1,197.58 Cr. |
Divi’s Laboratories Limited | 82.53 | 83.22 | 15.35% | 564.87 | 9,360.00 Cr. |
IPO Open Date: | July 14, 2025 |
IPO Close Date: | July 16, 2025 |
Face Value: | ₹2 Per Equity Share |
IPO Price Band: | ₹540 to ₹570 Per Share |
Issue Size: | Approx ₹3,395 Crores |
Offer for Sale: | Approx 5,95,61,404 Equity Shares |
Issue Type: | Book Build Issue |
IPO Listing: | BSE & NSE |
Retail Quota: | Not more than 35% |
QIB Quota: | Not more than 50% |
NII Quota: | Not more than 15% |
DRHP Draft Prospectus: | Click Here |
RHP Draft Prospectus: | Click Here |
Anchor Investors List: | Click Here |